For ABI but have read for Parkinson's as well?
Annovis Bio Secures U.S. Patent for Treat... - Cure Parkinson's
Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap
Written by
Headache58
To view profiles and participate in discussions please or .
2 Replies
•
futile try to just get money
What a shame
That us why I don't like the current way of research, too much manipulation in the results for monetary purposes
Not what you're looking for?
You may also like...
Annovis Bio Announces Approval for EU Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease
This trial is already open in the United States, and I believe some on this forum are...
ANNOVIS BIO ANNOUNCES POSITIVE FDA NOTICE FOR BUNTANETAP PHASE 3 CLINICAL TRIAL IN PARKINSON'S DISEASE
https://irpages2.eqs.com/websites/annovis/English/431010/us-press-release.html?airportNewsID=e4e0b40
Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury
Interesting Read: Intranasal delivery of mitochondria targeted neuroprotective compounds for...
ANNOVIS BIO ANNOUNCES POSITIVE FDA FEEDBACK FOR BUNTANETAP PHASE 3 CLINICAL DEVELOPMENT IN PARKINSON'S DISEASE (ANVS401)
https://irpages2.eqs.com/websites/annovis/English/431010/us-press-release.html?releaseID=111474&d=20
Annovis Bio have published the results of their dose-finding, biomarker study of buntanetap in 14 early Alzheimers & 14 Parkinsons patients
have published the results of their dose-finding, biomarker study of buntanetap (known as Posiphen...